作者: Ken Garber
DOI: 10.1038/NBT0807-838
关键词: Physical medicine and rehabilitation 、 Stroke treatment 、 Stroke 、 Medicine
摘要: Despite the high-profile failures of two more stroke drugs in late-stage trials, biotech firms are persevering with new approaches and treatments.